In Friday’s trading, the VanEck BDC Income ETF saw a notable increase of approximately 2.3%. Key contributors to this performance included New Mountain Finance, which rose 4%, and Goldman Sachs BDC, up 3.8%.
Conversely, the ARK Genomic Revolution ETF experienced a decline of about 5%. This downturn was primarily influenced by Prime Medicine, which fell by 13.6%, and Beam Therapeutics, down 10.6%.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
